Peripheral blood mononuclear cells (PBMCs) were collected from 55-year old male patient with a confirmed diagnosis of hemorrhagic Moyamoya disease (MMD). PBMCs were reprogrammed using Sendai virus particles delivering the four Yamanaka factors. A footprint-free hiPSC line was characterized by the expression of pluripotency markers and a normal karyotype. These cells were able to give rise to Embryoid Bodies and to a progeny of differentiated cells belonging to the 3 germ layers. This hiPSC line represents a suitable tool for modelling in vitro MMD disease to investigate the cellular mechanisms underlying the occurrence of this pathology.
Resource details
Blood sample was donated by a 55-year old male patient affected by Moyamoya disease (MMD; Papa Giovanni XXIII Hospital, Bergamo, Italy). Patient was admitted to the emergency room for a large intracerebral hematoma of the left frontal lobe. The computed tomography angiography did not show any vascular malformation but, on the other side, disclosed a significant stenosis of the distal intracranial internal carotid artery on both sides suggestive of MMD. Postoperative digital subtraction angiography confirmed the diagnosis of MMD.
Patient's PBMCs were purified and infected with Sendai virus particles (Yang et al. 2008) , delivering 3 different vectors encoding for the Yamanaka reprogramming genes (OCT4, SOX2, KLF4, and c-Myc; Takahashi et al., 2007) . After two weeks, several colonies with the typical iPSC-like phenotype appeared in the cultures. These were then Stem Cell Research 17 (2016) Carpenter et al., 2003) . The lack of residual Sendai virus particles was confirmed at passage 10 (Fusaki et al., 2009) , suggesting that the expression of OCT4, SOX2, KLF4, and c-Myc was indicative of an effective complete reprogramming process (Fig. 1B) . The in vitro differentiation competence was assessed by Embryoid Body assay, giving rise to mature cells belonging to the three different germ layers, immunoreactive for ectoderm (βIII-Tubulin), mesoderm (α-SMA) and endoderm (TROMA-1) markers ( Fig. 2A ) (Itskovitz-Eldor et al., 2000; Carpenter et al., 2003) . Moreover, differentiated MMD HEM#30 iPSCs expressed transcript levels of FGF5 (ectoderm), Nestin (neuro-ectoderm), TBrachyury (mesoderm), SOX-17 (endoderm) comparable to those assessed in a differentiated reference commercial hiPSC line (Fig. 2B ).
Materials and methods

PBMCs collection and freezing
Patient's PBMCs were isolated in BD Vacutainer CPT Cell Preparation tubes and separated by centrifugation (30 min, 1800g at room temperature). Then they were resuspended in 35 ml of PBS, centrifuged at 300 g for 15 min at room temperature and aliquots of 2 * 10 6 cells were cryopreserved in fetal bovine serum (FBS) supplemented with 10% DMSO.
PBMCs thawing and infection with Sendai virus
Thawed cells were cultured in 24 well-plates in PBMC expansion medium, composed by StemPro-34 Serum Free Medium Basal Medium (Thermo Fisher Scientific), StemPro-34 Nutrient Supplement, 200 mM GlutaMAX (Thermo Fisher Scientific), 1% penicillin/streptomycin (Life Technologies), 100 ng/ml stem cell factor (SCF, Prepotech), 100 ng/ml FLT-3 (Thermo Fisher Scientific), 20 ng/ml Interleukin-6 (IL-6) (Thermo Fisher Scientific), 20 ng/ml Interleukin-3 (IL-3) (Thermo Fisher Scientific). The medium was replaced daily.
After 4 days, PBMCs were transduced in feeder-free conditions with the components provided with the CytoTune-iPS 2.0 Sendai Reprogramming Kit (Thermo Fisher Scientific), according the manufacturer's instructions. 20 days post-infection, optimal iPSC-like colonies were marked, picked and transferred in Essential 8 medium (E8 medium; Thermo Fisher Scientific) on Geltrex-coated wells. Both MMD HEM#30 iPSC line and commercial hiPSC line (GIBCO, Thermo Fisher Scientific) were maintained in E8 medium, performing daily medium change and regular splitting every 3-4 days with an EDTA-based dissociation solution.
In vitro differentiation
hiPSCs were collected and dissociated in cell clumps, plated in low attachment wells in 4 ml of Essential 8 medium supplemented with 2 mg/ml of PVA (polyvinyl alcohol, Santa Cruz Biotechnology) and 10 μg/ml of y-27632 ROCK inhibitor (TebuBIO). After two days, cell aggregates were shifted to a 1:1 mix of Essential 6 medium (E6 medium; Thermo Fisher Scientific) and E8 medium supplemented with 2 mg/ml of PVA. From the following day until the end of the experiment, cells were maintained in E6 medium. At day 7, Embryoid Bodies (EBs) were collected and plated on Geltrex-coated wells, and let to differentiate for further 7 days. Medium was changed every other day.
RNA isolation, polymerase chain reaction (PCR) and quantitative-PCR (qPCR)
RNA was isolated with the TRIzol Reagent (Thermo Fisher Scientific) following the manufacture's protocol, then retro-transcribed with iScript cDNA Synthesis Kit (BioRad). cDNA was used to verify the expression of specific target genes by RT-PCR (Reverse Transcription-PCR, primers reported in Table 1 ) or qRT-PCR (quantitative RT-PCR), using the SsoAdvanced Universal SYBR Green Supermix Kit. qRT-PCR data were analyzed according to the comparative ΔΔCt method and normalized by using GAPDH housekeeping gene.
Immunofluorescence analysis
Cells were fixed in PFA 4% for 15 min at room temperature, permeabilized with Triton 0.3% for 10 min at room temperature, and incubated in blocking solution (FBS 5%, Triton 0.3% in PBS) for 1 h. Hybridization with the primary antibodies reported in the Table 2 was performed overnight at 4°C in antibody solution (FBS 2% and Triton 0.2% in PBS). The signal was revealed by the appropriate secondary antibodies (Table 2) , while nuclei were counterstained with Hoechst 33258 1 μg/ ml (Thermo Fisher Scientific). Images were acquired with the microscope Leica DM IL Led Fluo and the camera Leica DFC450 C (Leica Microsystem).
Western blot assay
Cells were lysed in RIPA buffer and 20 μg of total lysate were fractionated on 8% SDS-polyacrylamide gel, blotted onto PVDF membranes with the TransBlot Turbo apparatus (BioRad) and hybridized overnight at 4°C with the primary antibodies ( Table 2 ). The signal was detected with appropriate HRP-conjugated secondary antibodies (BioRad) and ECL Clarity system (BioRad), using the chamber UVITECH Cambridge (Uvitech).
Karyotyping
Cell cultures were treated with 10 ng/ml colcemid (Gibco KaryoMAX Colcemid solution in PBS, Thermo Fisher Scientific) for 16 h (overnight) at 37°C. Metaphases were collected according to standard protocols. Briefly, cells were incubated with hypotonic solution (0.075 M KCl for 15 min at room temperature) and fixed in acetic acid/methanol (1:3 v/v). Air-dried metaphase spreads slides were then analyzed by QFQ banding. Microscope observation was performed using a Nikon Eclipse 90i (Nikon Instruments) equipped with the acquisition and analysis Genikon software (Nikon Instruments). 
